Interaction of purified lipoteichoic acid with the classical complement pathway.
Glycerophosphate-containing lipoteichoic acids (LTAs) interact with the first component of the classical complement pathway (C1). This resulted in the activation of the classical complement pathway in serum, shown by the consumption of C1, C2, and C4. The dose-dependent interaction of LTAs with purified C1 and C1q was dependent on the negative charges of the phosphate groups of LTA. It was reduced by charge compensation through D-alanine ester substituents and by sterical hindrance through di- and trihexosyl residues linked to position 2 of the glycerol moieties. The charge density of LTA may also play a role: poly(digalactosylglycerophosphate) LTAs, in which the phosphate groups are in a greater distance from each other, were less effective, and the loss of micellar organization by deacylation of LTA drastically reduced the complement activation capacity.
D003166:Complement Activating Enzymes / Q000378:metabolism; D003167:Complement Activation / Q000187:drug effects*; D003172:Complement C1 / Q000378:metabolism; D015922:Complement C1q; D003171:Complement Pathway, Classical / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008070:Lipopolysaccharides; D008823:Micelles; D010712:Phosphatidic Acids / Q000494:pharmacology*; D013682:Teichoic Acids / Q000494:pharmacology*
D003172:Complement C1; D008070:Lipopolysaccharides; D008823:Micelles; D010712:Phosphatidic Acids; D013682:Teichoic Acids; C009900:lipoteichoic acid; D015922:Complement C1q; D003166:Complement Activating Enzymes